Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,932 | -23,524 | -17,060 | -9,964 | -25,834 |
| Depreciation Amortization | 2,728 | 2,321 | 1,647 | 887 | 3,525 |
| Income taxes - deferred | 21 | -1 | 30 | 53 | 109 |
| Accounts receivable | 5,464 | 4,278 | 4,814 | 5,083 | 8,749 |
| Accounts payable and accrued liabilities | 1,494 | 3,210 | 4,000 | -1,746 | -20,165 |
| Other Working Capital | 14,038 | 18,299 | 19,566 | 9,184 | -20,974 |
| Other Operating Activity | -4,373 | -5,293 | -7,335 | -2,422 | 21,067 |
| Operating Cash Flow | $-10,560 | $-710 | $5,662 | $1,075 | $-33,523 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -203 | -193 | -184 | -1,356 |
| Investing Cash Flow | $-11 | $-203 | $-193 | $-184 | $-1,356 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,289 | 2,289 | 2,289 | N/A | 5,614 |
| Debt Repayment | -6,435 | -6,398 | -6,325 | -37 | -9,307 |
| Common Stock Issued | 25,566 | 25,402 | 25,337 | 210 | 38,695 |
| Other Financing Activity | -6 | -6 | -6 | 0 | -1,874 |
| Financing Cash Flow | $21,414 | $21,287 | $21,295 | $173 | $33,128 |
| Beginning Cash Position | 11,298 | 11,298 | 11,298 | 11,298 | 13,049 |
| End Cash Position | 22,141 | 31,672 | 38,062 | 12,362 | 11,298 |
| Net Cash Flow | $10,843 | $20,374 | $26,764 | $1,064 | $-1,751 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,560 | -710 | 5,662 | 1,075 | -33,523 |
| Capital Expenditure | -11 | -203 | -193 | -184 | -1,356 |
| Free Cash Flow | -10,571 | -913 | 5,469 | 891 | -34,879 |